2026/2027 EVITP Certification Final Ultimate Study Companion and Exam Preparation Manual: In-Depth Concept Review, Complete Test Bank, Realistic Practice Questions, and Final Knowledge Assessment

A postmenopausal woman with an intact uterus is started on systemic hormone therapy. Which regimen is most appropriate? A. Bisphosphonate plus calcium only B. Estrogen alone C. Testosterone alone D. Estrogen plus progestogen Correct Answer: D. Estrogen plus progestogen Rationale: Women with an intact uterus require progestogen with systemic estrogen to protect the endometrium from estrogen-induced hyperplasia and possible malignancy. Estrogen alone is generally reserved for women who have had a hysterectomy. Testosterone may be considered for selected cases of low libido but is not standard menopausal hormone therapy. Bisphosphonates treat osteoporosis, not vasomotor symptoms. Question 2 A 49-year-old woman reports irregular menstrual cycles, hot flashes, and night sweats. She has not gone 12 months without a period. Which reproductive stage best describes her condition? A. Primary ovarian insufficiency B. Postmenopause C. Perimenopause D. Premenopause Correct Answer: C. Perimenopause Rationale: Perimenopause is the transition period before menopause when menstrual cycles become irregular and vasomotor symptoms such as hot flashes and night sweats often appear. The woman has not yet met the definition of postmenopause, which requires 12 consecutive months without menstruation. Premenopause usually refers to regular cycles before the transition. Primary ovarian insufficiency is typically considered when ovarian failure occurs before age 40. Question 3 A breast cancer survivor has troubling hot flashes and wants a non-hormonal option. Which medication is most appropriate based on the provided content? A. Raloxifene as first-line treatment for hot flashes B. Paroxetine C. Estrogen plus progestogen D. Systemic estrogen Correct Answer: B. Paroxetine Rationale: Paroxetine is a non-hormonal option that can reduce menopausal hot flashes and night sweats. It is especially relevant when hormone therapy is inappropriate, such as in many breast cancer survivors. Systemic estrogen is generally avoided in breast cancer survivors unless highly specialized evaluation supports it. Raloxifene may reduce breast cancer risk and improve bone density but can worsen hot flashes. Question 4 A 53-year-old woman reports that her last menstrual period was 13 months ago. She has had no bleeding since. Which term best describes her reproductive status? A. Postmenopause B. Late perimenopause C. Anovulatory adolescence D. Early perimenopause Correct Answer: A. Postmenopause Rationale: Postmenopause is defined as 12 consecutive months without menstruation, assuming there is no other pathologic or physiologic cause. Since this woman has had 13 months without bleeding, she meets the definition. Early and late perimenopause involve menstrual irregularity before the final menstrual period is confirmed. Anovulatory adolescence is unrelated to the menopausal transition. Question 5 A woman with menopausal hot flashes asks about clonidine. Which explanation is most accurate? A. It is a vaginal estrogen preparation B. It is an alpha-2 agonist that can reduce hot flash frequency C. It is contraindicated in all postmenopausal women D. It is the most effective therapy for osteoporosis Correct Answer: B. It is an alpha-2 agonist that can reduce hot flash frequency Rationale: Clonidine is a non-hormonal option that may reduce hot flash frequency. It is not the most effective osteoporosis treatment and does not act as vaginal estrogen. It is not contraindicated in all women, although side effects and comorbidities must be considered. It may be useful when hormone therapy is inappropriate or not preferred. Question 6 A 51-year-old woman asks whether her age is typical for natural menopause. Which response is most accurate? A. Natural menopause usually occurs only after surgical removal of the ovaries B. Natural menopause usually occurs after 65 years C. Natural menopause usually occurs around 51 years D. Natural menopause usually occurs at 35 years Correct Answer: C. Natural menopause usually occurs around 51 years Rationale: The median age of natural menopause is approximately 51 years. This means many women experience menopause around this age, although variation is normal. Menopause before age 40 is considered premature and requires evaluation. Menopause after 65 is later than typical. Surgical menopause is different from natural menopause because it results from removal of ovarian function rather than the usual gradual reproductive aging process. Question 7 A woman who had a total hysterectomy develops severe hot flashes and has no contraindications to hormone therapy. Which regimen is most appropriate? A. Raloxifene alone B. Estrogen plus progestogen C. Estrogen alone D. Progestogen alone Correct Answer: C. Estrogen alone Rationale: After hysterectomy, endometrial protection is no longer needed because the uterus has been removed. Therefore, estrogen alone is usually sufficient for treating menopausal vasomotor symptoms in women without a uterus. Progestogen is added primarily to reduce endometrial risk. Raloxifene may help bone health and reduce breast cancer risk but may worsen hot flashes and is not the best treatment for severe vasomotor symptoms. Question 8 Which finding most directly reflects the hormonal change responsible for many menopausal symptoms? A. Declining cortisol B. Declining estrogen C. Rising progesterone D. Rising thyroid hormone Correct Answer: B. Declining estrogen Rationale: Declining estrogen is the characteristic hormonal change during the menopausal transition. It contributes to vasomotor symptoms, vaginal dryness, sleep disturbance, bone loss, lipid changes, and genitourinary syndrome of menopause. Progesterone also changes, but estrogen decline is the major driver of many clinical features. Thyroid and cortisol changes may cause symptoms that overlap with menopause, but they are not the defining hormonal change. Question 9 A woman with a history of breast cancer needs treatment for hot flashes. Which additional non-hormonal medication may be appropriate? A. High-dose progesterone without evaluation B. Testosterone as first-line therapy C. Oral estrogen D. Venlafaxine Correct Answer: D. Venlafaxine Rationale: Venlafaxine, an SNRI, is used as a non-hormonal treatment for hot flashes and may be appropriate for women with a history of breast cancer. Oral estrogen is usually avoided because of hormone-sensitive cancer concerns. Progesterone without a clear indication is not first-line. Testosterone may help selected cases of decreased libido but is not first-line for vasomotor symptoms in breast cancer survivors. Question 10 A 52-year-old woman has irregular periods and vasomotor symptoms. Which laboratory result would support the diagnosis of menopause transition? A. Low serum sodium B. Elevated hemoglobin A1c C. Elevated FSH above 25 IU/L D. Low FSH below 5 IU/L Correct Answer: C. Elevated FSH above 25 IU/L Rationale: Elevated follicle-stimulating hormone reflects reduced ovarian feedback as estrogen production declines. In a woman of typical menopausal age with irregular menses and vasomotor symptoms, an FSH level above 25 IU/L can support the diagnosis. However, menopause is often diagnosed clinically. Hemoglobin A1c and sodium may identify other health problems but do not specifically support menopause diagnosis.